BridgeBio Pharma Inc
XBER:2CL
BridgeBio Pharma Inc
XBER:2CL
Price:
0.057
EUR
Market Closed
Market Cap:
€8.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BridgeBio Pharma Inc
XBER:2CL
|
US |
|
M
|
Mitsui Chemicals Inc
SWB:MSI
|
JP |
|
R
|
Randstad NV
SWB:RSH
|
NL |
|
B
|
BW Energy Ltd
OSE:BWE
|
BM |
|
W
|
Worthington Industries Inc
XBER:WTH
|
US |
|
B
|
Banco de Sabadell SA
XBER:BDSB
|
ES |
|
S
|
Smoore International Holdings Ltd
OTC:SMORF
|
CN |
|
P
|
Park National Corp
AMEX:PRK
|
US |
|
G
|
GlaxoSmithKline PLC
F:GS7A
|
UK |
|
Zurich Insurance Group AG
F:ZFI1
|
CH |
|
OMV AG
OTC:OMVKY
|
AT |
|
P
|
Petroleo Brasileiro SA Petrobras
SWB:PJXC
|
BR |
|
A
|
Allegion PLC
SWB:60A
|
IE |
|
Murata Manufacturing Co Ltd
TSE:6981
|
JP |
|
N
|
Neodecortech SpA
LSE:0DEQ
|
IT |
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
P
|
Photronics Inc
SWB:PQ2
|
US |
|
T
|
Toyota Industries Corp
F:TAH
|
JP |
Multiples-Based Value
The Multiples-Based Value for 
BridgeBio Pharma Inc (2CL) under the Base Case is hidden
EUR.
Compared with the current market price of 0.057 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
2CL Multiples-Based Value
LOCKED
